N
ELAN icon

Natixis’s Elanco Animal Health ELAN Stock Holding History

Natixis’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-84,747
Closed -$1.92M – 1178
2025
Q4 		$1.92M Buy
+84,747
New +$1.84M 0.01% 611
2025
Q2 		– Sell
-732
Closed -$7.51K – 1070
2025
Q1 		$7.51K Buy
732
+667
+1,026% +$7.55K ﹤0.01% 899
2024
Q4 		$787 Sell
65
-1,435
-96% -$18.8K ﹤0.01% 1007
2024
Q3 		$22K Buy
+1,500
New +$20.9K ﹤0.01% 822
2024
Q2 		– Sell
-19,573
Closed -$319K – 1046
2024
Q1 		$319K Sell
19,573
-439
-2% -$6.86K ﹤0.01% 672
2023
Q4 		$298K Sell
20,012
-788,163
-98% -$8.93M ﹤0.01% 668
2023
Q3 		$9.08M Buy
808,175
+585,700
+263% +$6.8M 0.07% 218
2023
Q2 		$2.24M Buy
222,475
+115,850
+109% +$1.08M 0.02% 410
2023
Q1 		$1M Sell
106,625
-1,196,691
-92% -$14.1M 0.01% 521
2022
Q4 		$15.9M Buy
1,303,316
+835,291
+178% +$10.4M 0.09% 202
2022
Q3 		$5.81M Sell
468,025
-737,096
-61% -$12.9M 0.03% 379
2022
Q2 		$23.7M Sell
1,205,121
-457,603
-28% -$10.8M 0.09% 151
2022
Q1 		$43.4M Buy
1,662,724
+210,802
+15% +$5.61M 0.15% 149
2021
Q4 		$41.2M Buy
1,451,922
+794,591
+121% +$24.7M 0.14% 137
2021
Q3 		$21M Buy
657,331
+641,793
+4,130% +$21.5M 0.07% 226
2021
Q2 		$539K Sell
15,538
-857,102
-98% -$28.3M ﹤0.01% 703
2021
Q1 		$25.7M Buy
872,640
+667,251
+325% +$20.5M 0.08% 223
2020
Q4 		$6.3M Sell
205,389
-3,148,425
-94% -$96.1M 0.02% 475
2020
Q3 		$93.7M Buy
3,353,814
+2,968,719
+771% +$75.2M 0.69% 35
2020
Q2 		$8.26M Sell
385,095
-1,474,932
-79% -$32.6M 0.06% 217
2020
Q1 		$41.6M Buy
1,860,027
+1,503,137
+421% +$41.2M 0.33% 73
2019
Q4 		$10.5M Buy
+356,890
New +$9.7M 0.06% 274
2019
Q3 		– Sell
-412,552
Closed -$13.9M – 836
2019
Q2 		$13.9M Buy
+412,552
New +$13.4M 0.11% 176

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Natixis's ELAN Position: Q1 2026 in Review

Natixis sold out of Elanco Animal Health (ELAN) in Q1 2026, closing a stake of 84,747 shares — an estimated $1.92M sold.

Natixis first reported a position in ELAN in Q2 2019 and held it in 23 quarters. The position peaked at $93.7M in Q3 2020. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Natixis reported no remaining Elanco Animal Health position as of Q1 2026 after selling out during the quarter.
  • Natixis sold 84,747 Elanco Animal Health shares in Q1 2026, an estimated $1.92M.
  • Natixis first reported a position in Elanco Animal Health in Q2 2019 and held it in 23 quarters.
  • Natixis's Elanco Animal Health position peaked at $93.7M in Q3 2020.
  • 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.